Boehringer Ingelheim Director of Business Development Salaries in Kingston, NY
The average Boehringer Ingelheim Director of Business Development in Kingston, NY earns an estimated $209,441 annually, which includes an estimated base salary of $159,694 with a $49,747 bonus. Boehringer Ingelheim's Director of Business Development compensation is $43,175 more than the US average for a Director of Business Development. Director of Business Development salaries at Boehringer Ingelheim in Kingston, NY can range from $73,000 - $390,000.
In Kingston, NY, The Business Development Department at Boehringer Ingelheim earns $11,680 more on average than the Design Department.
Last updated 13 days ago.
- $159,694
- avg. base
- $49,747
- avg. bonus
Director of Business Development Salaries at Boehringer Ingelheim
In Kingston, NY, Directors of Business Development earn $4,348 more than Directors of Business Development.
Compensation at Boehringer Ingelheim by Department
In Kingston, NY, The Business Development Department averages $11,680 more than the Design Department, and $2,461 less than the Engineering Department
Director of Business Development Compensation by Gender (All Companies)
The average female Director of Business Development at companies similar size to Boehringer Ingelheim reported making $205,320, while the average male Director of Business Development at similar sized companies reported making $214,912.
Director of Business Development Compensation by Ethnicity (All Companies)
The average African American/Black Director of Business Development at companies similar size to Boehringer Ingelheim reported making $217,667, while the average Hispanic or Latino Director of Business Development at similar sized companies reported making $185,667.
How Directors of Business Development at Boehringer Ingelheim Rate Their Compensation
The majority of Directors of Business Development at Boehringer Ingelheim believe they're compensated fairly. The vast majority (73%) of Directors of Business Development at Boehringer Ingelheim are satisfied with their benefits. See more compensation ratings at Boehringer Ingelheim
